These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8999671)

  • 21. Epidemiology of HDV infection in Southern Italy.
    Giusti G; Sagnelli E
    Prog Clin Biol Res; 1987; 234():367-77. PubMed ID: 3628387
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis markers in hemodialysis patients].
    Leblebicioğlu H; Günaydin M; Cengiz K; Işlek I
    Mikrobiyol Bul; 1993 Oct; 27(4):321-6. PubMed ID: 7505387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delta infection in patients and HBsAg carriers.
    Ketiladze ES; Vyazov SO; Chernovetsky MA; Mikhailov MI; Bugayeva NP; Kozlova TP
    Prog Clin Biol Res; 1987; 234():461-6. PubMed ID: 3628413
    [No Abstract]   [Full Text] [Related]  

  • 26. HDV infection in Cyprus.
    Eleftheriou A; Teloni F; Ioannou P
    Prog Clin Biol Res; 1993; 382():277-85. PubMed ID: 8502692
    [No Abstract]   [Full Text] [Related]  

  • 27. Seroprevalence of hepatitis D virus and its risk factors in the west of Iran.
    Mohammad Alizadeh AH; Ranjbar M; Tehrani AS; Keramat F; Mamani M; Rezazadeh M; Aini P; Khalilian A; Majlesi A; Hajilooi M
    J Microbiol Immunol Infect; 2010 Dec; 43(6):519-23. PubMed ID: 21195980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hepatitis delta virus in Algiers (Algeria).
    Belabbes EH
    Prog Clin Biol Res; 1987; 234():443-4. PubMed ID: 3628410
    [No Abstract]   [Full Text] [Related]  

  • 30. Minor role of hepatitis B virus in the causation of chronic liver disease in Somalia indicated by a case-control study.
    Bile KM; Abdirahman M; Aden C; Norder H; Magnius L; Lindberg G; Nilsson LH
    Trans R Soc Trop Med Hyg; 1991; 85(1):104-8. PubMed ID: 1712517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
    Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
    Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B.
    Fattovich G; Boscaro S; Noventa F; Pornaro E; Stenico D; Alberti A; Ruol A; Realdi G
    J Infect Dis; 1987 May; 155(5):931-5. PubMed ID: 3559292
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of delta antigen/antibody in various HBsAg positive patients in Saudi Arabia.
    Shobokshi OA; Serebour FE
    Prog Clin Biol Res; 1987; 234():471-5. PubMed ID: 2819896
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology of hepatitis delta virus infection in Ethiopia.
    Rapicetta M; Hailu K; Ponzetto A; Hele C; Morace G; Bekura D; Bisanti L; Forzani B; Pasquini P; Macagno S
    Prog Clin Biol Res; 1987; 234():445-9. PubMed ID: 3628411
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum anti-HD in patients with high prevalences of HBV infection.
    Doris R; Cadrobbi P; Aneloni V; Zorzi D; Pornaro E
    Prog Clin Biol Res; 1987; 234():393. PubMed ID: 3628395
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of HDV infection in Japan.
    Mitamura K
    Prog Clin Biol Res; 1991; 364():81-7. PubMed ID: 2020725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?
    Buti M; Jardi R; Allende H; Cotrina M; Rodriguez F; Viladomiu L; Esteban R; Guardia J
    J Med Virol; 1996 May; 49(1):66-9. PubMed ID: 8732862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Course and prognosis of acute HDV hepatitis.
    Caredda F; Antinori S; Re T; Pastecchia C; Moroni M
    Prog Clin Biol Res; 1987; 234():267-76. PubMed ID: 3628381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.